RAPT Therapeutics, Inc.
RAPTDelisted Mar 3, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001673772
RAPT Therapeutics, Inc. was delisted on Mar 3, 2026; its insiders filed their last Form 4 on Mar 5, 2026; 106 institutions reported holding it in 13F filings for Q4 2025, worth $1.02B in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by RAPT Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for RAPT Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Gray Mary Ann | Director | 0 | Mar 5, 2026 | 2 |
| Dombkowski Ashley L. | Director | 0 | Mar 5, 2026 | 2 |
| Young Rodney KB | CHIEF FINANCIAL OFFICER | 0 | Mar 5, 2026 | 1 |
| Brockstedt Dirk G. | CHIEF SCIENTIFIC OFFICER | 0 | Mar 5, 2026 | 1 |
| Braunstein Scott | Director | 0 | Mar 5, 2026 | 2 |
| Wong Brian Russell | PRESIDENT AND CEO | 0 | Mar 5, 2026 | 1 |
| Lyons-Williams Lori | Director | 0 | Mar 5, 2026 | 2 |
| Giordano Michael F | Director | 0 | Mar 5, 2026 | 2 |
| Kozick Linda | Director | 0 | Mar 5, 2026 | 2 |
| Ho William | CHIEF MEDICAL OFFICER | 15,020 | Jun 24, 2025 | 0 |
| Robbins Wendye | Director | 6,500Indirect | Apr 2, 2025 | 0 |
| Column Group II, LP | Other: Former 10% Owner | 0Indirect | Dec 23, 2024 | 0 |
| Column Group IV-A, LP | 10% Owner | 0Indirect | Dec 23, 2024 | 0 |
| Column Group IV, LP | 10% Owner | 0Indirect | Dec 23, 2024 | 0 |
| Column Group IV GP, LP | 10% Owner | 0Indirect | Dec 23, 2024 | 0 |
| TCG IV GP, LLC | 10% Owner | 0Indirect | Dec 23, 2024 | 0 |
| Goeddel David V | 10% Owner | 0Indirect | Dec 23, 2024 | 0 |
| Svennilson Peter | 10% Owner | 0Indirect | Dec 23, 2024 | 0 |
| Kutzkey Tim | 10% Owner | 0Indirect | Dec 23, 2024 | 0 |
| Column Group II GP, LP | 10% Owner | 0Indirect | Dec 23, 2024 | 0 |
| Ponoi Capital, LP | 10% Owner | 0Indirect | Dec 23, 2024 | 0 |
| Ponoi Management, LLC | 10% Owner | 0Indirect | Dec 23, 2024 | 0 |
| Ponoi Capital II, LP | 10% Owner | 0Indirect | Dec 23, 2024 | 0 |
| Ponoi II Management, LLC | 10% Owner | 0Indirect | Dec 23, 2024 | 0 |
| Column Group LLC | 10% Owner | 0Indirect | Dec 23, 2024 | 0 |
| Rieflin William JL | Director | – | May 23, 2024 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 20, 2023 (view filing) | Jan 19 | 1 day | Ho WilliamChief Medical Officer | SSale | −5.00K | $25.56 | −$127.8K | −12.5%35.1K after | |
| Jan 26, 2023 (view filing) | Jan 24 | 2 days | Ho WilliamChief Medical Officer | SSale | −5.00K | $30.00 | −$150.0K | −14.3%30.1K after | |
| Mar 13, 2023 (view filing) | Mar 7 | 6 daysLate | Ho WilliamChief Medical Officer | SSale | −5.00K | $29.62 | −$148.1K | −16.4%25.5K after | |
| Mar 15, 2023 (view filing) | Mar 14 | 1 day | Robbins WendyeDirector | PPurchase | +2.50K | $18.99 | +$47.5K | +20.2%14.9K after | 3 lots |
| Mar 15, 2023 (view filing) | Mar 14 | 1 day | Robbins WendyeDirector | PPurchase | +2.50K | $20.05 | +$50.1K | +62.5%6.50K after | |
| Apr 20, 2023 (view filing) | Apr 19 | 1 day | Ho WilliamChief Medical Officer | SSale | −5.00K | $18.88 | −$94.4K | −19.2%21.0K after | |
| Aug 22, 2023 (view filing) | Aug 18 | 4 days | Ho WilliamChief Medical Officer | SSale | −2.50K | $18.92 | −$47.3K | −10.5%21.3K after | |
| Oct 4, 2023 (view filing) | Oct 3 | 1 day | Ho WilliamChief Medical Officer | SSale | −2.50K | $15.77 | −$39.4K | −11.7%18.8K after | |
| Nov 29, 2023 (view filing) | Nov 28 | 1 day | Ho WilliamChief Medical Officer | SSale | −1.50K | $13.72 | −$20.6K | −7.9%17.5K after | |
| Dec 22, 2023 (view filing) | Dec 21 | 1 day | Ho WilliamChief Medical Officer | SSale | −2.50K | $21.68 | −$54.2K | −14.3%15.0K after | |
| Jan 8, 2024 (view filing) | Jan 5 | 3 days | Brockstedt Dirk G.CHIEF SCIENTIFIC OFFICER | SSale | −898 | $22.78 | −$20.5K | −3.1%27.8K after |